SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 216 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,386 | -8.3% | 413 | 0.0% | 0.00% | – |
| Q2 2023 | $12,415 | -17.0% | 413 | 0.0% | 0.00% | – |
| Q1 2023 | $14,963 | +99653.3% | 413 | 0.0% | 0.00% | – |
| Q4 2022 | $15 | -99.9% | 413 | -17.2% | 0.00% | – |
| Q3 2022 | $17,000 | -43.3% | 499 | -51.0% | 0.00% | – |
| Q2 2022 | $30,000 | -3.2% | 1,018 | +4.6% | 0.00% | – |
| Q1 2022 | $31,000 | +6.9% | 973 | 0.0% | 0.00% | – |
| Q4 2021 | $29,000 | -95.1% | 973 | -94.9% | 0.00% | -100.0% |
| Q1 2017 | $595,000 | +24.0% | 19,000 | 0.0% | 0.02% | +16.7% |
| Q4 2016 | $480,000 | +2.1% | 19,000 | 0.0% | 0.02% | -5.3% |
| Q3 2016 | $470,000 | +21.4% | 19,000 | 0.0% | 0.02% | +18.8% |
| Q2 2016 | $387,000 | +33.4% | 19,000 | 0.0% | 0.02% | +33.3% |
| Q1 2016 | $290,000 | +28.3% | 19,000 | +13.1% | 0.01% | +20.0% |
| Q4 2015 | $226,000 | – | 16,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
| MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
| Versant Capital Management, Inc | 16 | $463 | 0.00% |